Core Laboratories Q3 2024 Adj EPS $0.25 Beats $0.23 Estimate, Sales $134.40M Miss $134.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
Core Laboratories reported Q3 2024 earnings per share of $0.25, surpassing the consensus estimate of $0.23. However, sales of $134.40 million slightly missed the estimate of $134.46 million. Sales increased by 7.22% compared to the same period last year.
October 23, 2024 | 9:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Core Laboratories' Q3 2024 EPS of $0.25 beat expectations, but sales of $134.40M slightly missed. Sales grew 7.22% YoY, indicating positive growth despite the minor sales miss.
The earnings per share beat indicates strong profitability, which is positive for the stock. The slight miss in sales is negligible, especially with a 7.22% YoY growth, suggesting overall positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100